2022 COCA Calls/Webinars Information, Summaries, & Slide Sets

Title: New 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain

Date:
Thursday, November 17, 2022

Presenter:

Deborah Dowell, MD, MPH
CAPT, U.S. Public Health Service
Chief Clinical Research Officer
Division of Overdose Prevention
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention


Title: 2022-2023 Seasonal Influenza Testing and Treatment During the COVID-19 Pandemic

Date:
Tuesday, November 15, 2022

Presenters:

Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Office of the Director
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention


Title: Update on Monkeypox in Children, Adolescents, and People Who are Pregnant or Breastfeeding

Date:
Thursday, October 27, 2022

Presenters:

Romeo R. Galang, MD, MPH
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention

Jeremy Gold, MD, MS
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention

Anne Kimball, MD, MPH
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention


Title: Melioidosis in the United States: What Clinicians Need to Know Following Newly Discovered Endemicity

Date:
Thursday, October 13, 2022

Presenters:

Julia Petras, MSPH, BSN, RN
Epidemic Intelligence Service Officer
Bacterial Special Pathogens Branch
Division of High-Consequence Pathogens & Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Caroline A. Schrodt, MD, MSPH
Lieutenant Commander, U.S. Public Health Service
Bacterial Special Pathogens Branch
Division of High-Consequence Pathogens & Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: Update on 2022 Ebola Outbreak in Uganda 

Date: Wednesday, October 12, 2022

Presenters:

Trevor Shoemaker, PhD, MPH
Epidemiologist
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention

Mary Choi, MD, MPH
Medical Officer
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention


Title: Situational Update for Clinicians about Severe Monkeypox Virus Infections

Date: Thursday, October 6, 2022

Presenters:

Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Subject Matter Expert, Vaccine Task Force and Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Caroline Schrodt, MD, MSPH
LCDR, U.S. Public Health Service
Lead, Clinical Escalations Team
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Jemma Alarcón, MD, MPH
Los Angeles County Department of Public Health
Epidemic Intelligence Service Officer
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Alexandra Dretler, MD
Adjunct Professor
Infectious Diseases
Emory University


Title: What Clinicians Need to Know about Dengue in the United States

Date:
Thursday, September 29, 2022

Presenters:

Laura Adams, DVM, MPH
Epidemiologist
Dengue Branch, Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

Liliana Sánchez-González, MD, MPH
Epidemiologist
Dengue Branch, Division of Vector-Borne Diseases
Centers for Disease Control and Prevention


Title: Evaluating and Supporting Patients Presenting with Cardiovascular Symptoms Following COVID

Date:
Tuesday, September 20, 2022

Presenters:

Miriam Nji, MD, MPH
Medical Epidemiologist
Post-COVID Conditions Team
Chronic Viral Diseases Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Jonathan Whiteson, MD, FAAPMR
Medical Director, Cardiac and Pulmonary Rehabilitation
Co-Director, NYU Post COVID Care Program
Rusk Rehabilitation, NYU Langone Health

Alba Azola, MD, FAAPMR
Assistant Professor
Co-director of the Post-Acute COVID-19 Team (JH PACT) Program
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine


Title: 2022–2023 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers

Date:
Thursday, September 15, 2022

Presenters:

Fatimah S. Dawood, MD
Medical Officer Epidemiologist
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention 

Kristina A. Bryant, MD, FAAP
Member, AAP Committee on Infectious Diseases
Professor of Pediatrics, University of Louisville School of Medicine
Hospital Epidemiologist at Norton Children’s Hospital
Director for System Pediatric Epidemiology and Infectious Diseases, Norton Children’s Medical Group, Louisville, KY


Title: Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older

Date:
Tuesday, September 13, 2022

Presenters:

Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Lead, COVID-19 Coordinating Unit
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Lead, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: 2022-2023 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

Date:
Thursday, September 8, 2022

Presenters:

Lisa Grohskopf, MD, MPH
CAPT, U.S. Public Health Service
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Lead, Vaccine Policy Unit
COVID-19 Response
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention


Title: Polio in New York: How to Recognize and Report Polio, and Reinforce Routine Childhood Polio Vaccination

Date:
Thursday, September 1, 2022

Presenters:

Farrell Tobolowsky, DO, MS
LCDR, U.S. Public Health Service
Clinical Task Force Lead
2022 NYS Polio Response
Centers for Disease Control and Prevention

Emily Lutterloh, MD, MPH
Director, Division of Epidemiology
New York State Department of Health

Janell Routh, MD, MHS
CAPT, U.S. Public Health Service
Incident Manager
2022 NYS Polio Response
Centers for Disease Control and Prevention

Georgina Peacock, MD, MPH
Director, Division of Immunization Services
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention


Title: CDC and FDA Update: Interim Clinical Considerations for Monkeypox Vaccination

Date:
Thursday, August 11, 2022

Presenters:

Jennifer McQuiston, DVM, MS
CAPT, U.S. Public Health Service
Incident Manager
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
U.S. Food & Drug Administration

Elissa Meites, MD, MPH
CAPT, U.S. Public Health Service
Vaccine Team, Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Elisabeth (Liz) Velazquez, RN, BSN, COHN-S
Nurse Educator, Clinical Education Lead
Vaccine Team, Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention


Title: Recommendations for the Novavax COVID-19 Vaccine Primary Series in Adults Ages 18 Years and Older

Date:
Thursday, July 28, 2022

Presenters:
Evelyn Twentyman, MD, MPH
Lead, Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Chris Duggar, MPH
Lead, COVID Vaccine Unit
COVID-19 Response
Centers for Disease Control and Prevention

Tanya Myers, PhD, MSc
Co-Lead, v-safe Team
COVID-19 Immunization Safety Unit
COVID-19 Response
Centers for Disease Control and Prevention


Title: Monkeypox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination

Date:
Tuesday, July 26, 2022

Presenters:
María E. Negrón Sureda, DVM, PhD, MS
Veterinary Medical Officer
Epidemiology Task Force Lead
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Christina L. Hutson PhD, MS
Laboratory and Testing Task Force Lead
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Stephen Flores, PhD
Behavioral Scientist
Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Yon Yu, PharmD
CAPT, U.S. Public Health Service
Regulatory Affairs and Clinical Guidelines Team Lead
Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention


Title: Monkeypox: Updates about Clinical Diagnosis and Treatment

Date:
Wednesday, June 29, 2022

Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Leandro A. Mena, MD, MPH, FIDSA
Director, Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention

Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: Recommendations for Pfizer-BioNTech and Moderna COVID-19 Vaccine Primary Series in Children 6 Months through 5 Years Old

Date: Wednesday, June 22, 2022

Presenters:
Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Clinical Guidelines Lead
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Kevin Chatham-Stephens, MD, MPH
CDR, U.S. Public Health Service
Pediatric Vaccine Planning and Implementation Lead
Vaccine Coordination Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: What Clinicians Need to Know About Available Therapeutic Options for COVID-19

Date: Thursday, June 16, 2022

Presenters:
Pragna Patel, MD, MPH
Chief Medical Officer, COVID-19 Response
Centers for Disease Control and Prevention

Eric Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Clinical Guidelines Team
National Institutes of Health

John Farley, MD, MPH
Director, Office of Infectious Diseases
Office of New Drugs, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Meg Sullivan, MD, MPH, FAAP
Chief Medical Officer
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services


Title: What Clinicians Need to Know about Monkeypox in the United States and Other Countries

Date: Tuesday, May 24, 2022

Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Laura Hinkle Bachmann, MD, MPH, FIDSA, FACP
Chief Medical Officer
Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Control
Centers for Disease Control and Prevention

Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: Clinical Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

Date: Thursday, May 19, 2022

Presenters:
L. Amanda Ingram, MPH
Epidemiologist Supervisor
Infectious Diseases & Outbreaks Division
Alabama Department of Public Health

Jacqueline Tate, PhD
Epidemiology Team Lead, Viral Gastroenteritis Branch
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Helena Gutierrez, MD
Medical Director, Pediatric Liver Transplant Program
Assistant Professor, Division of Pediatric Gastroenterology, Hepatology, and Nutrition
The University of Alabama at Birmingham

Elizabeth A. Moulton, MD, PhD
Assistant Professor of Pediatrics
Transplant Infectious Diseases
Baylor College of Medicine
Texas Children’s Hospital


Title: Updated Guidance for Clinicians on COVID-19 Vaccines

Date: Thursday, May 5, 2022

Presenters:
Jennifer Cope, MD, MPH
Medical Officer
Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Michelle Haddad, PhD
Director of Post-COVID Neuropsychology Clinic
Director of Inpatient Neuropsychology
Departments of Rehabilitation Medicine & Neurology
Emory University School of Medicine

Jeffrey S. Fine, MD, FAAPMR
Associate Professor and Vice Chair, Rusk Rehabilitation
Dept of Rehabilitation Medicine and Dept of Medicine
NYU Langone Health

Talya K. Fleming, MD
Assistant Professor and Medical Director
JFK Johnson Rehabilitation Institute
Dept of Physical Medicine and Rehabilitation
Hackensack Meridian Medicine


Title: Updated Guidance for Clinicians on COVID-19 Vaccines

Date: Thursday, February 24, 2022

Presenters:
Sara Oliver, MD MSPH
LCDR, U.S. Public Health Service
Lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Chief Medical Officer, Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention


Title: COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children

Date: Thursday, February 10, 2022

Presenters:
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Shana Godfred-Cato, DO, FAAP
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anna Yousaf, MD
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention


Title: Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings

Date: Thursday, January 13, 2022

Presenters:
Lauri Hicks, DO
Captain, U.S. Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Alexander Kallen, MD, MPH
Chief, Prevention and Response Branch
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Pragna Patel, MD, MPH
Deputy Principal Incident Manager, COVID-19 Response
Senior Medical and Science Advisor, HIV Prevention Branch
Division of Global HIV and TB
Centers for Disease Control and Prevention


Title: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19

Date: Wednesday, January 12, 2022

Presenters:
Lauri Hicks, DO
Captain, US Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention

Stephanie Troy, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Aimee Hodowanec, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Alice K. Pau, PharmD
Executive Secretary, NIH COVID-19 Treatment Guidelines Panel
Staff Scientist (Clinical)
Clinical Pharmacy Specialist
Division of Clinical Research
National Institute of Allergy & Infectious Diseases
National Institutes of Health


Sign up for COCA Newsletters and Announcements

Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address: